PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $426,059 | -43.9% | 19,012 | +1.9% | 0.00% | -33.3% |
Q2 2023 | $758,902 | -16.4% | 18,660 | -0.5% | 0.01% | -25.0% |
Q1 2023 | $908,008 | +30.9% | 18,745 | +3.2% | 0.01% | +14.3% |
Q4 2022 | $693,473 | -20.8% | 18,168 | +4.1% | 0.01% | -22.2% |
Q3 2022 | $876,000 | +25.7% | 17,447 | +0.2% | 0.01% | +28.6% |
Q2 2022 | $697,000 | +8.6% | 17,405 | +1.2% | 0.01% | +40.0% |
Q1 2022 | $642,000 | -5.7% | 17,200 | +0.6% | 0.01% | 0.0% |
Q4 2021 | $681,000 | +5.9% | 17,103 | -1.0% | 0.01% | 0.0% |
Q3 2021 | $643,000 | -11.6% | 17,272 | +0.4% | 0.01% | -16.7% |
Q2 2021 | $727,000 | -14.1% | 17,204 | -3.8% | 0.01% | -14.3% |
Q1 2021 | $846,000 | -21.5% | 17,877 | +1.2% | 0.01% | -30.0% |
Q4 2020 | $1,078,000 | +35.1% | 17,671 | +3.5% | 0.01% | +25.0% |
Q3 2020 | $798,000 | +25.7% | 17,074 | +36.4% | 0.01% | -11.1% |
Q2 2020 | $635,000 | +9.3% | 12,520 | -3.9% | 0.01% | -10.0% |
Q1 2020 | $581,000 | – | 13,022 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |